Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis. Stander S, Yosipovitch G, Legat FJ, Lacour JP, et al. N Engl J Med 2020;382:706-716.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stander S, Yosipovitch G, Legat FJ, Lacour JP, et al. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis. N Engl J Med 2020;382:706-716.
PMID: 32074418